Xilio Therapeutics Inc. (XLO)
NASDAQ: XLO
· Real-Time Price · USD
0.70
-0.00 (-0.38%)
At close: Aug 15, 2025, 3:59 PM
0.70
-0.74%
After-hours: Aug 15, 2025, 06:54 PM EDT
Xilio Therapeutics Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -54.3M | -58.24M | -62.8M | -65.53M | -70.96M | -76.4M | -81.22M | -84.26M | -89.52M | -88.22M | -85.46M | -81.92M | -80.49M | -75.8M | -76.87M | -75.44M | -52.27M |
Depreciation & Amortization | 1.7M | 1.64M | 1.72M | 1.8M | 1.84M | 1.9M | 1.94M | 1.95M | 1.91M | 1.85M | 1.75M | 1.66M | 1.59M | 1.5M | 1.45M | 1.38M | 1.01M |
Stock-Based Compensation | 6.14M | 6.43M | 4.92M | 5.21M | 5.5M | 5.45M | 7.27M | 7.28M | 8.19M | 8.42M | 8.68M | 7.9M | 6.19M | 4.96M | 3.25M | 2.85M | 1.84M |
Other Working Capital | 1.59M | -4.48M | 2.35M | 38.91M | 38.7M | 5.33M | 3.48M | 223K | -980.95K | -3.52M | -2.74M | -2.56M | -5.74M | -8.98M | -5.16M | 112K | 3.29M |
Other Non-Cash Items | 36.63M | 69.66M | 72.94M | 38.22M | 36.41M | 3.42M | 200K | 236K | 202K | 224K | 221K | 360K | 395K | 395K | 75K | -40K | -127.78K |
Deferred Income Tax | n/a | n/a | -1.34M | -1.34M | -1.33M | -1.33M | 3K | 2K | n/a | n/a | 4K | 159K | 207K | 222K | -87K | -196K | -244K |
Change in Working Capital | 32.83M | -2.96M | 1.83M | 39.22M | 7.69M | -1.66M | -1.61M | -5.17M | -917K | 2M | 142K | -3.48M | -6.54M | -11.8M | -4.2M | 5.22M | 3.64M |
Operating Cash Flow | 21.1M | -18.38M | -17.65M | -17.34M | -53.87M | -68.62M | -73.42M | -79.96M | -80.14M | -75.72M | -74.66M | -75.47M | -78.85M | -80.75M | -76.29M | -66.04M | -45.91M |
Capital Expenditures | -58K | -36K | -30K | -21K | -316K | -486K | -995K | -1.33M | -1.78M | -1.87M | -1.74M | -1.52M | -1.18M | -1.1M | -830K | -1.29M | -852.72K |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | n/a | n/a | n/a | n/a | n/a | 1.73M | 1.73M | 1.73M | 1.73M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Investing Cash Flow | -58K | -36K | -30K | -21K | -316K | -486K | -995K | -1.33M | -1.78M | -1.87M | -1.74M | -1.52M | -1.18M | -1.1M | -830K | -1.29M | -852.72K |
Debt Repayment | -28K | -3.38M | -5.07M | -7.31M | -8.42M | -6.75M | -5.08M | -2.86M | -1.75M | -85K | -86K | 223K | -110K | -110K | -116K | -474K | -120K |
Common Stock Repurchased | -4.27M | -4.27M | -4.08M | 194K | 194K | 194K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 25.76M | 25.75M | 17.61M | 17.61M | 202K | 202K | 148K | 140K | n/a | 16K | 115.86M | 115.88M | 115.88M | 115.89M | 197K | 189K | 184K |
Financial Cash Flow | 33.07M | 29.2M | 19.36M | 19.36M | -683.23K | -1.64M | -25.92K | -45.68K | -65.69K | -69K | 115.78M | 116.1M | 115.77M | 260.67M | 144.97M | 144.6M | 144.95M |
Net Cash Flow | 55.11M | 10.6M | 1.49M | -428K | -59.28M | -75.66M | -79.35M | -84.01M | -83.67M | -77.66M | 39.38M | 39.11M | 35.74M | 178.82M | 67.84M | 77.28M | 98.19M |
Free Cash Flow | 21.04M | -18.41M | -17.68M | -17.37M | -54.19M | -69.11M | -74.41M | -81.28M | -81.92M | -77.59M | -76.4M | -76.99M | -80.04M | -81.85M | -77.12M | -67.33M | -46.76M |